Watch Demo

China Antidiabetics Industry Outlook 2024 - 2028

See how China Antidiabetics performed compared to key markets such as Germany, France and Italy.

Key Market Indicators

Chinese insulin exports are projected to reach approximately $520 million by 2028, up from around $420 million in 2023. This marks a compound annual growth rate (CAGR) of 3.4%. Since 1997, the country's insulin supply has increased at an average annual rate of 4.5%. In 2023, China ranked fourth globally in insulin exports, just behind Italy, which recorded exports of $416 million. France, Italy, and China occupied the second, third, and fourth positions, respectively. On the import side, China's insulin imports are expected to hit nearly $925 million by 2028, rising from about $815 million in 2023. This reflects an average annual growth rate of 1.9%. Since 1997, the nation's demand for imported insulin has surged by 2.5% annually.

Marketing Banner

China Antidiabetics Market Data and Forecasts

How much will China Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in China
Forecast: Import of Insulin in Dosage Forms to China
Forecast: Import of Insulin to China
Forecast: Export of Insulin in Dosage Forms from China
Forecast: Export of Insulin from China
More in Antidiabetics Industry for 2028